adalat au

JOHANNESBURG (Reuters) – Two doses of Pfizer-BioNTech’s COVID-19 vaccine appear to have given 70% protection against hospitalisation in South Africa

Read more

20 mg of accutane

ATLANTA — An experimental bi-specific, T-cell engaging (BiTE) monoclonal antibody, mosunetuzumab (Genentech), has induced high response rates and long-duration responses

Read more